Switzerland · Series C startup

Who invested in Numab

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$55Mraised across 1 round since 2025, from 1 source

Latest round
Series C, $55MJan 2025
Investors
5
See who backed them

The rounds

  1. Jan 2025

Everyone who backed them

BlackRockAsset manager1round
Novo HoldingsVC firm1round
Cormorant Asset ManagementPrivate equity1round
RTW Investments LLCGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Numab as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Eisai InnovationCorporate VCPer its own site

Quick answers about Numab

Who invested in Numab?

Numab's investors include Mitsubishi UFJ Capital, BlackRock, Novo Holdings, Cormorant Asset Management and RTW Investments LLC.

How much has Numab raised?

Numab has raised $55M across 1 round since 2025.

When did Numab last raise?

Numab's most recent round was a Series C of $55M in Jan 2025.

What was Numab's biggest round?

Its most recent round, $55M in Jan 2025, is also its largest on record.

Who backed Numab first?

Numab's first round on record, in Jan 2025, was backed by Mitsubishi UFJ Capital, BlackRock and Novo Holdings and 2 others.

What stage is Numab at?

Numab's latest named round is a Series C, in Jan 2025.

Where is Numab based?

Numab is based in Switzerland.

Companies like Numab

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.